To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease
NCT ID: NCT02347319
Last Updated: 2015-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
262 participants
INTERVENTIONAL
2012-04-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
\- To evaluate the efficacy of Biphenyl dimethyl dicarboxylate(DDB)/Garlic Oil in patients with elevated transaminase chronic liver disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease
NCT01393665
Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease
NCT01393678
Crassostrea Gigas for Liver Health
NCT02992470
Carnitine and Liver Mitochondria Fatty Acid Processing
NCT03193125
Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis
NCT02024295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pennel
This group will treated with DDB 25mg/Garlic oil 50mg for 12 weeks.
Pennel
Pennel 2 Tablet, Legalon Placebo 1 tablet, Tid
Legalon
This group will treated with Silymarin 140mg for 12 weeks.
Legalon
Pennel Placebo 2 Tablet, Legalon 1 tablet, Tid
Placebo
This group will treated with Placebo for 12 weeks.
Placebo
Pennel Placebo 2 Tablet, Legalon Placebo 1 tablet, Tid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pennel
Pennel 2 Tablet, Legalon Placebo 1 tablet, Tid
Legalon
Pennel Placebo 2 Tablet, Legalon 1 tablet, Tid
Placebo
Pennel Placebo 2 Tablet, Legalon Placebo 1 tablet, Tid
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with more 60 ALT in screening period.
* To evaluate ALT and AST at least three months.
* Serum Transaminase abnormal(before 6months), chronic liver disease or fatty liver, liver disease medical treatment at more than 30days
* Women of childbearing age get her consent for contraception, pregnancy urine test result negative.
Exclusion Criteria
* Current treatment on another clinical trial
* Pregnancy or breastfeeding
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PharmaKing
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The catholic university of korea, Bucheon ST. Mary's Hosipital
Bucheon-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P2010-PN004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.